Related Experiment Video
Updated: Aug 8, 2025

06:17
Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
22.0K
Recent Developments in Vaccines against Flaviviruses and Alphaviruses
Young Chan Kim1, Arturo Reyes-Sandoval1,2
1The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7DG, UK.
Vaccines
|February 28, 2023
Summary
Newly emerging zoonotic and vector-borne viruses pose significant global health threats. Understanding these viral threats is crucial for effective public health strategies and outbreak prevention.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Emerging infectious diseases (EIDs) represent a continuous threat to global public health.
- Zoonotic and vector-borne viruses are primary drivers of recent and ongoing outbreaks.
- The 21st century has witnessed an increasing frequency of viral emergence with pandemic potential.
Discussion:
- The complex interplay between environmental changes, human activity, and pathogen evolution facilitates viral emergence.
- Effective surveillance systems are essential for early detection and rapid response to novel viral threats.
- International collaboration is vital for managing cross-border outbreaks and mitigating global health risks.
Key Insights:
- Zoonotic spillover events are a major source of novel viral pathogens.
- Vector-borne diseases are expanding their geographic range due to climate change and globalization.
- Genomic sequencing and molecular epidemiology are critical tools for tracking viral evolution and transmission.
Outlook:
- Continued investment in research and development for diagnostics, therapeutics, and vaccines is paramount.
- Strengthening global health security infrastructure is necessary to prepare for future viral pandemics.
- Integrated approaches combining One Health principles are needed to address the root causes of viral emergence.
Related Concept Videos
Vaccinations
45.1K
Overview
45.1K
Microorganisms in Medicine and Therapeutics
103
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
103
Viral Mutations
32.7K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.7K
Cross-reactivity
31.4K
Overview
31.4K

